Nestec S.a.

Societe Des Produits Nestle S.a.

Etienne Pouteau

Catherine Mace

Lionel Jean Rene Bovetto

Simina Popa Nita

Olivier Aprikian

Laurence Donato-Capel

Denis Breuille

Christophe Joseph Etienne Schmitt

Olivier Kevork Aprikian

The present invention relates to the treatment or prevention of conditions linked to reduced muscle mass or reduced muscle protein synthesis rate. A subject matter of the invention is a composition comprising complexes of whey protein micelles and pectin for use in the treatment or prevention of a condition selected from the group consisting of sarcopenia, muscle atrophy and negative nitrogen balance. Further aspects of the invention relate to the non-therapeutic use of a composition comprising complexes of whey protein micelles and pectin and a food composition.

Complexes of whey protein micelles and pectin and body muscle protein synthesis

The present invention relates to a composition comprising polysaccharides and whey protein micelles for use in the treatment or prevention of a disorder linked to an increase in plasma postprandial insulin in a subject. The invention relates also to the non-therapeutic use of a composition comprising polysaccharides and whey protein micelles to decrease plasma postprandial insulin concentration. A further aspect of the invention is a process for forming polysaccharide-whey protein micelle complexes.

Use of whey protein micelles and polysaccharides for improving insulin profile

The invention relates to whey protein micelles for use in the treatment and/or prevention of a disorder linked to an increase in insulin secretion and/or plasma IGF-1 concentration in an infant at risk of developing obesity or diabetes. The invention also relates to a nutritional composition for infants comprising whey protein micelles. Further, the invention relates to a non-therapeutic use of a nutritional composition for infants, comprising whey protein micelles.

Use of whey protein micelles for infants at risk of obesity or diabetes

A nutritional composition for infants comprises a protein source, a lipid source and a carbohydrate source wherein the lipid source includes at least 16 wt % linoleic acid and at least 2 wt % &#x3b1;-linolenic acid expressed as a percentage of total fatty acid content in each case and in amounts such that the ratio of linoleic acid:&#x3b1;-linolenic acid is in the range from 1 to 10.

Growing community of inventors

Lausanne, Switzerland

Etienne Pouteau